Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
However, the injections are done with a small needle and are generally well-tolerated
A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors
A small human study examining the addition of phentermine to liraglutide found no meaningful additional weight loss compared to liraglutide alone
ATTAIN-2 (NCT05872620) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of various doses of orforglipron with placebo in adults with obesity or overweight and type 2 diabetes
US$ 22.62
US$ 21.22
US$ 24.16
US$ 21.84
US$ 25.65
US$ 25.59
US$ 26.78
